[1]孟祥亚,马士超,陈秀民.加味桂枝茯苓丸口服联合低分子量肝素钙皮下注射预防全膝关节置换术后气滞血瘀证患者深静脉血栓形成的临床研究[J].中医正骨,2023,35(12):30-35.
　MENG Xiangya,MA Shichao,CHEN Xiumin.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(12):30-35.
点击复制

加味桂枝茯苓丸口服联合低分子量肝素钙皮下注射预防全膝关节置换术后气滞血瘀证患者深静脉血栓形成的临床研究()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第35卷
期数:
2023年12期
页码:
30-35
栏目:
临床研究
出版日期:
2023-12-20

文章信息/Info

作者:
孟祥亚1; 马士超2; 陈秀民2
1.河南中医药大学骨伤学院,河南 郑州 450046; 2.濮阳市中医医院,河南 濮阳 457003
Author(s):
MENG Xiangya1; MA Shichao2; CHEN Xiumin2
1.College of Orthopaedics and Traumatology of Henan University of Chinese Medicine,Zhengzhou 450046,Henan,China 2.Chinese Medicine Hospital of Puyang,Puyang 457003,Henan,China
关键词:
静脉血栓形成;  桂枝茯苓丸;  肝素; 低分子量;  血瘀气滞;  关节成形术; 置换; 膝;  临床试验
Keywords:
venous thrombosis;  Guizhi Fuling Wan;  heparin; low-molecular-weight;  syndrome of blood stasis and Qi stagnation;  arthroplasty; replacement; knee;  clinical trial
摘要:
目的:观察加味桂枝茯苓丸口服联合低分子量肝素钙皮下注射预防全膝关节置换术(total knee arthroplasty,TKA)后气滞血瘀证患者深静脉血栓形成(deep venous thrombosis,DVT)的临床疗效和安全性。方法:将TKA后辨证为气滞血瘀证的患者随机分为2组,分别采用加味桂枝茯苓丸口服联合低分子量肝素钙皮下注射(联合治疗组)与单纯低分子量肝素钙皮下注射(基础治疗组)治疗。加味桂枝茯苓丸水煎后口服,每日2次,每次200 mL; 低分子量肝素钙皮下注射,每日2次(间隔12 h),每次0.2 mL; 均连续治疗14 d。比较2组患者的DVT发生率、膝部疼痛视觉模拟量表(visual analogue scale,VAS)评分、凝血酶原时间(prothrombin time,PT)、活化部分凝血活酶时间(activated partial thromboplastin time,APTT)、血浆纤维蛋白原(fibrinogen,FIB)含量、血浆D-二聚体含量及不良反应发生率。结果:共纳入92例患者,每组46例。联合治疗组2例发生DVT,均为胫后静脉血栓; 基础治疗组9例发生 DVT,其中3例为胫前静脉血栓、6例为胫后静脉血栓; 联合治疗组的DVT发生率低于基础治疗组(χ2=5.059,P=0.024)。术后7 d、14 d,联合治疗组的膝部疼痛VAS评分均低于基础治疗组(t=2.141,P=0.035; t=9.528,P=0.001),联合治疗组的PT和APTT均长于基础治疗组(PT:t=5.292,P=0.001; t=3.160,P=0.002; APTT:t=3.007,P=0.003; t=2.975,P=0.004),联合治疗组的血浆FIB含量和D-二聚体含量均低于基础治疗组(FIB:t=2.337,P=0.022; t=5.184,P=0.001; D-二聚体:t=2.119,P=0.037; t=18.913,P=0.001)。联合治疗组未发生不良反应,基础治疗组2例患者术后2 d出现广泛皮下瘀斑; 2组患者不良反应发生率比较,差异无统计学意义(χ2=0.511,P=0.475)。结论:加味桂枝茯苓丸口服联合低分子量肝素钙皮下注射预防TKA后气滞血瘀证患者DVT的效果优于单纯应用低分子量肝素钙皮下注射,且前者减轻术后膝部疼痛的效果优于后者,但两者的安全性相当; 加味桂枝茯苓丸口服联合低分子量肝素钙皮下注射预防TKA后气滞血瘀证患者DVT的作用机制,可能与其抑制机体内源性和外源性凝血有关。
Abstract:
Objective:To observe the clinical outcomes and safety of oral application of Jiawei Guizhi Fuling Wan(加味桂枝茯苓丸,JWGZFLW)combined with subcutaneous injection of low-molecular-weight heparin calcium(LMWH-Ca)for prevention of deep venous thrombosis(DVT)in patients with qi-stagnation and blood-stasis syndrome who underwent total knee arthroplasty(TKA).Methods:The patients who were diagnosed with qi-stagnation and blood-stasis syndrome after TKA were randomized into 2 groups,and were treated with oral application of JWGZFLW in combination with subcutaneous injection of LMWH-Ca(combination treatment group)and subcutaneous injection of LMWH-Ca alone(basic treatment group)respectively.The JWGZFLW was decocted and then taken twice a day,200 mL at a time for consecutive 14 days,and the subcutaneous injection of LMWH-Ca was performed twice a day with a 12-hour interval between injections,0.2 mL at a time for consecutive 14 days.The incidence rate of DVT,knee pain visual analogue scale(VAS)score,prothrombin time(PT),activated partial thromboplastin time(APTT),plasma fibrinogen(FIB)level,plasma D-dimer level and incidence rate of adverse reactions were recorded and compared between the 2 groups respectively.Results:Ninety-two patients were enrolled in the study,46 cases in each group.Two patients experienced the posterior tibial vein thrombosis in combination treatment group; while,3 ones experienced the anterior tibial vein thrombosis and 6 ones experienced the posterior tibial vein thrombosis in basic treatment group.The incidence rate of DVT was lower in combination treatment group compared to basic treatment group(χ2=5.059,P=0.024).At postoperative day 7 and 14,the combination treatment group displayed the lower knee pain VAS score,longer PT and APTT,decreased plasma FIB and D-dimer levels compared with that of basic treatment group(VAS score:t=2.141,P=0.035; t=9.528,P=0.001; PT:t=5.292,P=0.001; t=3.160,P=0.002; APTT:t=3.007,P=0.003; t=2.975,P=0.004; FIB:t=2.337,P=0.022; t=5.184,P=0.001; D-dimer:t=2.119,P=0.037; t=18.913,P=0.001).No patients experienced adverse reactions in combination treatment group; while 2 patients developed extensive subcutaneous ecchymosis at postoperative day 2 in basic treatment group.There was no statistical difference in the incidence rate of adverse reactions between the 2 groups(χ2=0.511,P=0.475).Conclusion:The clinical outcome of combination of oral application of JWGZFLW with subcutaneous injection of LMWH-Ca is better than that of monotherapy of subcutaneous injection of LMWH-Ca in preventing of DVT in patients with qi-stagnation and blood-stasis syndrome after TKA,furthermore,the former is superior in alleviating postoperative knee pain compared to the latter with similar safety,and its mechanisms may be that it works by inhibiting the endogenous and exogenous blood coagulation within the body.

参考文献/References:

[1] YAU L K,HENRY F U,MAN HONG C,et al.Swelling assessment after total knee arthroplasty[J/OL].J Orthop Surg(Hong Kong),2022,30(3):10225536221127668[2023-09-01].https://pubmed.ncbi.nlm.nih.gov/36122907/.
[2] WENGER N,SEBASTIAN T,ENGELBERGER R P,et al.Pulmonary embolism and deep vein thrombosis:similar but different[J].Thromb Res,2021,206:88-98.
[3] LITOV L,PETKOV P,RANGELOV M,et al.Molecular mechanism of the anti-inflammatory action of heparin[J].Int J Mol Sci,2021,22(19):10730.
[4] 焦甲勋,朱小丽,索娜,等.苦碟子注射液联合低分子肝素预防全膝关节置换术后下肢深静脉血栓形成的临床研究[J].中国新药与临床杂志,2020,39(7):421-424.
[5] 曹锐.全髋关节置换术后应用血府逐瘀汤预防深静脉血栓临床观察[J].实用中医药杂志,2022,38(8):1281-1283.
[6] 徐凯捷,欧阳桂林,肖涟波,等.加味桃红四物汤联合那曲肝素钙预防单侧膝关节置换术后深静脉血栓的疗效观察[J].中国中医骨伤科杂志,2022,30(4):21-24.
[7] 薛莹,康宁,孙颖,等.桂枝茯苓丸加减辨治妇科肿瘤术后盆腔包裹性积液经验探析[J].中华中医药杂志,2023,38(2):675-678.
[8] 陈奕忠.桂枝茯苓丸加味治疗全膝关节置换术后小腿肌间静脉血栓的临床研究[D].福州:福建中医药大学,2021.
[9] 李国铭.桂枝茯苓丸加味联合利伐沙班治疗缺血性脑卒中后下肢深静脉血栓的疗效评价[J].中医药临床杂志,2019,31(7):1371-1374.
[10] 中国中医药研究促进会骨伤科分会.膝骨关节炎中医诊疗指南(2020年版)[J].中医正骨,2020,32(10):1-14.
中医正骨2023年12月第35卷第12期 J Trad Chin Orthop Trauma,2023,Vol.35,No.12(总915)
(总916)中医正骨2023年12月第35卷第12期 J Trad Chin Orthop Trauma,2023,Vol.35,No.12
[11] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:145.
[12] 中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2016,36(2):65-71.
[13] 中华医学会外科学分会血管外科学组,苏州大学附属第二医院,首都医科大学附属北京世纪坛医院,等.深静脉血栓形成的诊断和治疗指南(第三版)[J].中国血管外科杂志(电子版),2017,9(4):250-257.
[14] GUNTUPALLI S R,SPINOSA D,WETHINGTON S,et al.Prevention of venous thromboembolism in patients with cancer[J/OL].BMJ,2023,381:e072715[2023-09-01].https://pubmed.ncbi.nlm.nih.gov/37263632/.
[15] NEMETH B,NELISSEN R,ARYA R,et al.Preventing VTE following total hip and knee arthroplasty:is prediction the future?[J].J Thromb Haemost,2021,19(1):41-45.
[16] SHALHOUB J,LAWTON R,HUDSON J,et al.Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis:the GAPS non-inferiority RCT[J].Health Technol Assess,2020,24(69):1-80.
[17] 卢建华,沈淑劲,储小兵,等.活血利水法预防全膝置换术后下肢深静脉血栓的临床研究[J].中国中医骨伤科杂志,2022,30(2):31-35.
[18] 沈淑劲,卢建华,储小兵,等.活血利水法对全膝关节置换术后血栓弹力图及凝血功能的影响[J].中华中医药杂志,2022,37(2):1209-1212.
[19] 张兵兵,史晓林,吴连国,等.中药预防膝关节置换术后深静脉血栓形成的网状Meta分析[J].中医正骨,2021,33(6):27-35.
[20] 高朗,覃鹏,陈小芳,等.基于CiteSpace的桂枝茯苓丸相关研究可视化分析[J].中医药导报,2023,29(3):136-141.
[21] 满玉晶,张萌,吴效科,等.桂枝茯苓丸的药理作用及其临床应用[J].中医临床研究,2017,9(28):141-143.
[22] 陈智彬,李梦帆,钟美慧,等.下肢深静脉血栓形成发病机制研究[J].辽宁中医药大学学报,2020,22(8):143-146.
[23] 孙天瑶,蒋时枫,徐沁,等.靶向凝血因子FⅨa-FⅧa复合物结合位点的新型抗栓抗体[J].上海交通大学学报(医学版),2021,41(9):1133-1139.
[24] KODATO K,ISHIDA K,SHIBANUMA N,et al.Prothrombin time-international normalized ratio is a useful marker for edoxaban efficacy in preventing venous thromboembolism after total knee arthroplasty[J].Eur J Orthop Surg Traumatol,2018,28(1):103-108.
[25] 杨华,李致文,曹明善,等.纤维蛋白原、肿瘤坏死因子-α、D-二聚体可预测急性脑梗死患者溶栓后出血性转化的风险[J].内科急危重症杂志,2023,29(4):293-297.
[26] LIU Q,CHEN W,WANG Y L,et al.A new method of monitoring catheter-directed thrombolysis for deep venous thrombosis-application of D-dimer and fibrinogen testing[J].Phlebology,2022,37(3):216-222.

相似文献/References:

[1]马远,叶向阳,程省,等.P选择素、抗心磷脂抗体及活化蛋白C抵抗预测下肢创伤骨折术后深静脉血栓形成的临床研究[J].中医正骨,2019,31(08):31.
　MA Yuan,YE Xiangyang,CHENG Sheng,et al.Applied value of P-selectin,anticardiolipin antibody and activated protein c resistance in predicting deep venous thrombosis after the surgery for treatment of traumatic lower extremity fractures:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(12):31.
[2]周晓聪,丁玉梅,周前,等.补阳还五汤加减联合利伐沙班预防老年髋关节置换术后深静脉血栓形成的疗效观察及作用机制研究[J].中医正骨,2020,32(10):35.
　ZHOU Xiaocong,DING Yumei,ZHOU Qian,et al.A clinical study on the curative effects and mechanism of action of oral applications of Buyang Huanwu Tang Jiajian(补阳还五汤加减)and Rivaroxaban for preventing deep venous thrombosis after the surgery of hip replacement in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(12):35.

备注/Memo

备注/Memo:
基金项目:河南省中医药科学研究专项课题项目(2022ZY1192)
通讯作者:陈秀民 E-mail:CXm4427744@163.com
更新日期/Last Update: 1900-01-01